The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tomsicek Michael John since 2013.
This trader's CIK number is 1570392.
At the time of last reporting, Tomsicek Michael John was the Director of Milestone Pharmaceuticals Inc.. (stock ticker symbol MIST).
Also see all insider trading activities at Milestone Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | MIST | 15,000 | $79,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CBST | 0 | $0 | 1,904 | $130,323 | 25,695 | $470,000 |
| 2013 | CBST | 0 | $0 | 888 | $49,631 | 2,750 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CRSP | 0 | $0 | 25,000 | $3,471,000 | 27,833 | $443,750 |
| 2020 | CRSP | 0 | $0 | 24,000 | $2,148,720 | 24,000 | $426,000 |
1. Milestone Pharmaceuticals Inc. (MIST)
2. Cubist Pharmaceuticals Inc (CBST)
3. Crispr Therapeutics Ag (CRSP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-10-19 | MIST | Buy | 15,000 | 5.32 | 79,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-12-29 | CBST | Option Ex | 20,000 | 23.50 | 470,000 |
| 2014-08-18 | CBST | Sale | 409 | 63.67 | 26,043 |
| 2014-08-15 | CBST | Option Ex | 1,250 | .00 | 0 |
| 2014-05-14 | CBST | Sale | 499 | 69.00 | 34,431 |
| 2014-05-13 | CBST | Option Ex | 1,500 | .00 | 0 |
| 2014-04-15 | CBST | Option Ex | 1,361 | .00 | 0 |
| 2014-04-16 | CBST | Sale | 441 | 64.00 | 28,224 |
| 2014-02-18 | CBST | Sale | 555 | 75.00 | 41,625 |
| 2014-02-16 | CBST | Option Ex | 833 | .00 | 0 |
| 2014-02-15 | CBST | Option Ex | 751 | .00 | 0 |
| 2013-09-03 | CBST | Sale | 400 | 64.08 | 25,632 |
| 2013-08-15 | CBST | Option Ex | 1,250 | .00 | 0 |
| 2013-05-14 | CBST | Sale | 488 | 49.18 | 23,999 |
| 2013-05-13 | CBST | Option Ex | 1,500 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-08-06 | CRSP | Option Ex | 25,000 | 17.75 | 443,750 |
| 2021-08-06 | CRSP | Sale | 25,000 | 138.84 | 3,471,000 |
| 2021-03-10 | CRSP | Option Ex | 2,833 | .00 | 0 |
| 2020-09-01 | CRSP | Option Ex | 12,000 | 17.75 | 213,000 |
| 2020-09-01 | CRSP | Sale | 12,000 | 92.27 | 1,107,204 |
| 2020-08-03 | CRSP | Sale | 12,000 | 86.79 | 1,041,516 |
| 2020-08-03 | CRSP | Option Ex | 12,000 | 17.75 | 213,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tomsicek Michael John (Director of Milestone Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.